The no-observed-adverse-effect-level in drug safety evaluations: Use, issues, and definition(s) 论文
2005Regulatory Toxicology and Pharmacology引用 238
Animal testing and alternativesComputational Drug Discovery MethodsStatistical Methods in Clinical Trials
The no-observed-adverse-effect-level in drug safety evaluations: Use, issues, and definition(s) · 相关文章
暂无数据